Drugs / GED
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02902016 | Jul 2015 → Sep 2017 | lactose intolerance | University Hospital, Lille | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GED | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02902016 ↗ |
| Modality | Small molecule | “new synthetic PPARgamma ligand” NCT02902016 ↗ |
| Target | PPARG | “GED (PPARgamma modulator)” NCT02902016 ↗ |